[144] IBEX Ltd SEC Filing

Rhea-AI Filing Summary

Form 144 notice for IBEX Ltd shows a proposed sale of 45,027 common shares by the person named, with an aggregate market value of $1,751,100.03 and an approximate sale date of 09/16/2025 on NASDAQ. The shares were acquired as a grant on 08/07/2020. The filing also discloses a prior sale by the same person of 1,634 shares on 08/26/2025 for gross proceeds of $47,593.10. The filer certifies they have no undisclosed material adverse information about the issuer and includes the standard Rule 144 attestation language.

Positive

• Disclosure completeness: Filing includes acquisition date, nature of acquisition, broker details, and approximate sale date in accordance with Rule 144
• Attestation provided: The filer affirms no undisclosed material adverse information, following standard compliance practice

Negative

• Insider liquidity: Proposed sale of 45,027 shares (aggregate market value $1,751,100.03) indicates significant insider selling
• Limited context: Filing does not state whether a trading plan (Rule 10b5-1) governs the sales or disclose remaining beneficial ownership

Insights

Securities Analyst

TL;DR: Insider plans a sizeable Rule 144 sale of 45,027 shares (~$1.75M), following a small August sale.

The filing documents a proposed Rule 144 sale rather than an open-market press release; it indicates the shares were originally received as a grant in 2020 and are being offered on 09/16/2025. For investors, this is a disclosure of insider liquidity rather than a corporate event. The previously reported sale of 1,634 shares on 08/26/2025 for $47,593.10 provides recent execution context. The filing contains the required attestation about material undisclosed information but does not include any commentary on reasons for the sale or remaining beneficial ownership.

Corporate Governance Expert

TL;DR: Routine compliance filing showing an insider exercise/vested grant being sold under Rule 144; no governance red flags in the form itself.

The document meets Rule 144 disclosure requirements by identifying the class, quantity, acquisition date, and nature of acquisition (grant). It also lists the broker and exchange. The form does not allege any trading plan adoption dates or provide additional governance context. As filed, it is a standard disclosure of intended insider sales with no explicit governance issues disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	GLOBAL SHARES FINANCIAL SERVICES INC. 575 WASHINGTON BLVD FLOOR 9 WASHINGTON DC 20006	45027	1751100.03	13315077	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/07/2020	GRANT	ISSUER			45027	09/16/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT THOMAS DECHANT c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	08/26/2025	1634	47593.10

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for IBEX (IBEX) disclose?

The form discloses a proposed sale of 45,027 common shares with an aggregate market value of $1,751,100.03, approximate sale date 09/16/2025, to be executed on NASDAQ.

When were the shares being sold originally acquired?

The shares were acquired as a grant on 08/07/2020 according to the filing.

Did the filer recently sell any IBEX shares?

Yes. The filing reports a prior sale of 1,634 shares on 08/26/2025 for gross proceeds of $47,593.10.

Which broker and exchange are listed for the proposed sale?

The broker listed is Global Shares Financial Services Inc. (575 Washington Blvd, Floor 9, Washington DC) and the exchange is NASDAQ.

Does the Form 144 indicate undisclosed material information?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.